From paediatric formulations development to access: Advances made and remaining challenges

Litalien, Catherine, Berube, Sophie, Tuleu, Catherine, Gilpin, Andrea, Landry, Emilie Kate, Valentin, Marie, Strickley, Robert and Turner, Mark A ORCID: 0000-0002-5299-8656 (2022) From paediatric formulations development to access: Advances made and remaining challenges. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 88 (10). pp. 4349-4383.

Access the full-text of this item by clicking on the Open Access link.

Abstract

Developing suitable paediatric formulations and ensuring access to them by the greatest number of the 2.2 billion children worldwide are equally important to provide optimal pharmacotherapy. This review focuses on the progress made over the last two decades with paediatric oral formulations with respect to evidence for acceptability and dosing flexibility of liquid and solid oral dosage forms. It also discusses the clinical needs for, and the access to, paediatric formulations for existing authorised medicines. A significant body of new knowledge now supports the acceptability of solid oral dosage forms in children, resulting in an increasing number of medicines commercialised as multiparticulates, including minitablets that are starting to be brought to market. However, there are gaps with these formulations that deserve more research. Even though efforts have been made to identify medicines in need of age-appropriate formulations, there is no common priority list shared internationally. Such prioritisation would help to develop paediatric formulations with the greatest potential for providing a health benefit to children worldwide. In addition, available data highlight that paediatric formulation access is fragmented and unequal, with commercialisation of suitable paediatric formulations too often limited to some countries/regions. We propose actions to better align decisions during the development of paediatric formulations and promote a more globalised approach to facilitate registration pathways between different jurisdictions. Furthermore, discussions about alignment between approval, pricing and reimbursement processes should also happen, leaving working in siloes behind us. It is time for adults to start thinking outside the box for children.

Item Type:	Article
Uncontrolled Keywords:	access, flexible solid oral forms, liquid oral forms, minitablets, multiparticulates, paediatric formulations
Divisions:	Faculty of Health and Life Sciences Faculty of Health and Life Sciences > Institute of Life Courses and Medical Sciences
Depositing User:	Symplectic Admin
Date Deposited:	26 Sep 2023 09:47
Last Modified:	26 Sep 2023 09:47
DOI:	10.1111/bcp.15293
Open Access URL:	https://discovery.ucl.ac.uk/id/eprint/10144585/1/B...
Related URLs:	Author Publisher
URI:	https://livrepository.liverpool.ac.uk/id/eprint/3173056